Australia’s first snapshot of families at risk of blindness from rare genetic eye disease

New research has revealed for the first time the number of Australian families affected by genetic mutations that cause the rare genetic eye disease Leber Hereditary Optic Neuropathy (LHON) – and the risk of going blind from the disease. The research, led by Professor David Mackey AO from the Lions Eye Institute and University of Western Australia and Dr. Isabel […]

Read more

First specific drug therapy for a severe early form of epilepsy

Epilepsy comes in a variety of forms. Those affected by a genetically determined variety have severe epileptic seizures as early as the first year of life. The disease is accompanied by severe developmental disorders: it is difficult for them to walk, they have difficulty concentrating and later have problems with speech, spelling and calculations. Until now, this form of epilepsy […]

Read more

After its first suspected delta variant community case, New Zealand goes into short, sharp nationwide lockdown

New Zealanders are back in their bubbles after Prime Minister Jacinda Ardern announced a three day alert level 4 lockdown for the entire country, and a seven day period for Auckland, following the confirmation of a community case—most likely infected with the Delta variant. This is the first community case since February and it’s more than a year since the […]

Read more

First signs of MS may often go undiagnosed

Early symptoms of multiple sclerosis may commonly be missed for years before the right diagnosis is made, a new study suggests. Researchers found that patients with MS had a higher-than-average number of medical appointments, with doctors of various specialties, for up to five years before their diagnosis. And for the most part, those visits were for neurological symptoms consistent with […]

Read more

First months decisive for immune system development

Many diseases caused by a dysregulated immune system, such as allergies, asthma and autoimmunity, can be traced back to events in the first few months after birth. To date, the mechanisms behind the development of the immune system have not been fully understood. Now, researchers at Karolinska Institutet show a connection between breast milk, beneficial gut bacteria and the development […]

Read more

Toward the first drug to treat a rare, lethal liver cancer

Treatment options for a deadly liver cancer, fibrolamellar carcinoma, are severely lacking. Drugs that work on other liver cancers are not effective, and although progress has been made in identifying the specific genes involved in driving the growth of fibrolamellar tumors, these findings have yet to translate into any treatment. For now, surgery is the only option for those affected—mostly […]

Read more

FDA approves first drug to treat Alzheimer's patients since 2003

FDA approves first drug to treat Alzheimer’s patients since 2003 despite controversy over mixed clinical trial results On Monday, the FDA approved aducanumab, which was developed by Biogen Inc, to treat Alzheimer’s disease The drug removes amyloid beta proteins from the brain and could slow down patients’ cognitive decline  Aducanumab is not only the first drug of its kind  but also […]

Read more

First genetically modified mosquitoes released in US

The biotech firm Oxitec has released its genetically modified mosquitoes in the Florida Keys, with the goal of suppressing wild, disease-carrying mosquito populations in the region. This is the first time genetically modified mosquitoes have been released in the U.S. Oxitec previously released its modified Aedes aegypti mosquitoes in Brazil, the Cayman Islands, Panama and Malaysia, and the company reported […]

Read more

FDA Approves Trodelvy, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival

FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 7, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to Trodelvy® (sacituzumab govitecan-hziy) for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease. The approval is supported by data […]

Read more

Colorado finds first cases of Brazil COVID variant that reinfects survivors easily

Colorado reported its first two cases of a COVID-19 variant that has proven adept at reinfecting people who already had the virus. The P.1 variant was first found in Brazil and pushed that country’s health system to the breaking point, even in areas where many people had already had the virus and were thought to be immune. Other South American […]

Read more
1 2 3 9